Coradyn Biosystems

Coradyn Biosystems is a biotechnology company focused on the development of advanced delivery systems for genetic medicines. The company's proprietary platform is engineered to achieve organ-selective delivery, specifically addressing the challenge of reaching tissues beyond the liver. By utilizing specialized lipid nanoparticle (LNP) technology, Coradyn aims to deliver therapeutic payloads such as mRNA and siRNA to previously inaccessible organs. The firm is led by a team of industry veterans with extensive experience in RNA therapeutics and drug delivery. Coradyn is currently in the pre-clinical stage, advancing a pipeline of programs targeting various genetic and rare diseases.